143 related articles for article (PubMed ID: 38288173)
1. Contrast-Induced Nephropathy in Interventional Cardiology: Incidence, Risk Factors, and Identification of High-Risk Patients.
Shuka N; Hasimi E; Kristo A; Simoni L; Gishto T; Shirka E; Zaimi Petrela E; Goda A
Cureus; 2023 Dec; 15(12):e51283. PubMed ID: 38288173
[TBL] [Abstract][Full Text] [Related]
2. Contrast Induced Nephropathy In High Risk Patients - Myth Or Reality.
Nabi Z; Anjum N; Rashid RM; Zahideen ZU
J Ayub Med Coll Abbottabad; 2021; 33(4):568-571. PubMed ID: 35124909
[TBL] [Abstract][Full Text] [Related]
3. A simple risk score model for predicting contrast-induced nephropathy after coronary angiography in patients with diabetes.
Zeng JF; Chen SQ; Ye JF; Chen Y; Lei L; Liu XQ; Liu Y; Wang Y; Lin JJ; Chen JY
Clin Exp Nephrol; 2019 Jul; 23(7):969-981. PubMed ID: 31049747
[TBL] [Abstract][Full Text] [Related]
4. Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography.
Calabrò P; Bianchi R; Caprile M; Sordelli C; Cappelli Bigazzi M; Palmieri R; Gigantino G; Limongelli G; Capozzi G; Cuomo S; Calabrò R
Minerva Cardioangiol; 2010 Feb; 58(1):35-40. PubMed ID: 20145594
[TBL] [Abstract][Full Text] [Related]
5. Use and efficacy of saline hydration and N-acetyl cysteine to prevent contrast-induced nephropathy in low-risk populations undergoing coronary artery angiography.
Calabrò P; Bianchi R; Crisci M; Caprile M; Bigazzi MC; Palmieri R; Golia E; De Vita A; Romano IJ; Limongelli G; Russo MG; Calabrò R
Intern Emerg Med; 2011 Dec; 6(6):503-7. PubMed ID: 21279477
[TBL] [Abstract][Full Text] [Related]
6. Impact of anemia on contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary interventions.
Li WH; Li DY; Han F; Xu TD; Zhang YB; Zhu H
Int Urol Nephrol; 2013 Aug; 45(4):1065-70. PubMed ID: 23225080
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.
Chen SL; Zhang J; Yei F; Zhu Z; Liu Z; Lin S; Chu J; Yan J; Zhang R; Kwan TW
Int J Cardiol; 2008 Jun; 126(3):407-13. PubMed ID: 17651830
[TBL] [Abstract][Full Text] [Related]
8. Pre-diabetes and the risk of contrast induced nephropathy in patients undergoing coronary angiography or percutaneous intervention.
Barbieri L; Verdoia M; Schaffer A; Cassetti E; Di Giovine G; Marino P; Suryapranata H; De Luca G
Diabetes Res Clin Pract; 2014 Dec; 106(3):458-64. PubMed ID: 25458324
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
[TBL] [Abstract][Full Text] [Related]
10. Contrast medium induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome: differences in STEMI and NSTEMI.
Wickenbrock I; Perings C; Maagh P; Quack I; van Bracht M; Prull MW; Plehn G; Trappe HJ; Meissner A
Clin Res Cardiol; 2009 Dec; 98(12):765-72. PubMed ID: 19851800
[TBL] [Abstract][Full Text] [Related]
11. Contrast-Induced Nephropathy in STEMI Patients With and Without Chronic Kidney Disease.
Jain T; Shah S; Shah J; Jacobsen G; Khandelwal A
Crit Pathw Cardiol; 2018 Mar; 17(1):25-31. PubMed ID: 29432373
[TBL] [Abstract][Full Text] [Related]
12. Contrast-induced nephropathy after percutaneous coronary intervention in simple lesions: risk factors and incidence are affected by the definition utilized.
Caruso M; Balasus F; Incalcaterra E; Ruggieri A; Evola S; Fattouch K; Bracale UM; Amodio E; Novo G; Andolina G; Novo S
Intern Med; 2011; 50(9):983-9. PubMed ID: 21532220
[TBL] [Abstract][Full Text] [Related]
13. Predictors of contrast-induced nephropathy in chronic total occlusion percutaneous coronary intervention.
Lin YS; Fang HY; Hussein H; Fang CY; Chen YL; Hsueh SK; Cheng CI; Yang CH; Chen CJ; Hang CL; Yip HK; Wu CJ
EuroIntervention; 2014 Feb; 9(10):1173-80. PubMed ID: 24561734
[TBL] [Abstract][Full Text] [Related]
14. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
Patti G; Ricottini E; Nusca A; Colonna G; Pasceri V; D'Ambrosio A; Montinaro A; Di Sciascio G
Am J Cardiol; 2011 Jul; 108(1):1-7. PubMed ID: 21529740
[TBL] [Abstract][Full Text] [Related]
15. Contrast induced nephropathy among patients with normal renal function undergoing coronary angiography.
Assareh A; Yazdankhah S; Majidi S; Nasehi N; Beladi Mousavi SS
J Renal Inj Prev; 2016; 5(1):21-4. PubMed ID: 27069963
[TBL] [Abstract][Full Text] [Related]
16. Frequency and risk factors of contrast-induced nephropathy after cardiac catheterization in type II diabetic patients: a study among Egyptian patients.
Sany D; Refaat H; Elshahawy Y; Mohab A; Ezzat H
Ren Fail; 2014 Mar; 36(2):191-7. PubMed ID: 24138570
[TBL] [Abstract][Full Text] [Related]
17. Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention.
Chong E; Shen L; Poh KK; Tan HC
Singapore Med J; 2012 Mar; 53(3):164-9. PubMed ID: 22434288
[TBL] [Abstract][Full Text] [Related]
18. Trimetazidine can prevent the occurrence of contrast-induced nephropathy after percutaneous coronary intervention in elderly patients with renal insufficiency.
Fu H; Zhang J; Zhang H; Zhang P; Fu X; Zeng Z; Zhang X; Li W; Yang S; Liu X; Fu N
Perfusion; 2021 Sep; 36(6):603-609. PubMed ID: 32909511
[TBL] [Abstract][Full Text] [Related]
19. Sodium bicarbonate versus isotonic saline for the prevention of contrast-induced nephropathy in patients with diabetes mellitus undergoing coronary angiography and/or intervention: a multicenter prospective randomized study.
Koc F; Ozdemir K; Altunkas F; Celik A; Dogdu O; Karayakali M; Gul EE; Erkorkmaz U; Kadi H; Akpek M; Kaya MG
J Investig Med; 2013 Jun; 61(5):872-7. PubMed ID: 23552179
[TBL] [Abstract][Full Text] [Related]
20. Association of contrast-induced nephropathy with risk of adverse clinical outcomes in patients with cardiac catheterization: From the CINC-J study.
Sato A; Aonuma K; Watanabe M; Hirayama A; Tamaki N; Tsutsui H; Toyoaki M; Ogawa H; Akasaka T; Yoshimura M; Takayama T; Sakakibara M; Suzuki S; Ishigami K; Onoue K; Saito Y;
Int J Cardiol; 2017 Jan; 227():424-429. PubMed ID: 27838134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]